FDA applicant

Novo Nordisk Diagnostics, Ltd.

Cambridge Cb4 4ws England, GB2 decisions1990–19910 recalls

FDA records 2 decisions for Novo Nordisk Diagnostics, Ltd. (Cambridge Cb4 4ws England, GB) from 1990 to 1991: 2 510(k) clearances. Most are in product codes LJC (Enzyme Linked Immunoabsorbent Assay…) and LIC (Antiserum, Coagglutination (Direct) Neisseria…). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Novo Nordisk Diagnostics, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Novo Nordisk Diagnostics, Ltd. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Novo Nordisk Diagnostics, Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Novo Nordisk Diagnostics, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Novo”

FDA records each applicant name separately; these may or may not be the same firm.

Novo Nordisk, Inc. 14 Novo Diagnostic Systems 2 Novo Nordisk Pharmaceuticals, Inc. 2 Novo Norodisk Pharmaceuticals, Inc. 1 Novo Nordisk A/S 1

Novo Nordisk Diagnostics, Ltd.

Which product codes does it file in?

What has FDA decided for it lately?

Other applicant names beginning “Novo”